Detalles de la búsqueda
1.
Systematic review of the efficacy, effectiveness and safety of MF59® adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
Rev Med Virol
; 33(3): e2329, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35142401
2.
Systematic review of the efficacy, effectiveness and safety of recombinant haemagglutinin seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
Rev Med Virol
; 33(3): e2331, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35106885
3.
Systematic review of the efficacy, effectiveness and safety of high-dose seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
Rev Med Virol
; 33(3): e2330, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35119149
4.
Systematic review of the efficacy, effectiveness and safety of cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
Rev Med Virol
; 33(3): e2332, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35137512
5.
Relative vaccine effectiveness against COVID-19 hospitalisation in persons agedâ¯≥â¯65â¯years: results from a VEBIS network, Europe, October 2021 to July 2023.
Euro Surveill
; 29(1)2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38179626
6.
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥â¯60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023.
Euro Surveill
; 29(3)2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240061
7.
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
Euro Surveill
; 29(8)2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38390651
8.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Euro Surveill
; 28(47)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997666
9.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Euro Surveill
; 28(47)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997665
10.
Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021.
Euro Surveill
; 27(7)2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35177166
11.
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022.
Euro Surveill
; 27(30)2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35904059
12.
Initial assessment of the COVID-19 vaccination's impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021.
Euro Surveill
; 26(48)2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34857068
13.
Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021.
Euro Surveill
; 26(47)2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34823641
14.
A description of a hepatitis A outbreak in men who have sex with men and public health measures implemented in Seine-Maritime department, Normandy, France, 2017.
BMC Public Health
; 20(1): 1441, 2020 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32962667
15.
Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020.
Euro Surveill
; 25(31)2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32762795
16.
Mortality and clinical outcomes in children treated with antiretroviral therapy in four African vertical programmes during the first decade of paediatric HIV care, 2001-2010.
Trop Med Int Health
; 22(3): 340-350, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27992677
17.
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Influenza Other Respir Viruses
; 18(4): e13292, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654485
18.
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Influenza Other Respir Viruses
; 18(2): e13255, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38403302
19.
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Influenza Other Respir Viruses
; 17(11): e13195, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38019704
20.
Completeness and timeliness of Salmonella notifications in Ireland in 2008: a cross sectional study.
BMC Public Health
; 10: 568, 2010 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-20860803